Follow on Google News News By Tag * Degeneration * Macular * Pipeline * Therapeutic * Clinical * Inhibitors * Drug * Amd * Globaldata * Implications * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Just Released: "Macular Degeneration - Pipeline Assessment and Market Forecasts to 2017"New Pharmaceuticals research report from GlobalData is now available from Fast Market Research
Summary GlobalData, the industry analysis specialist, has released its new report, "Macular Degeneration - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Macular Degeneration market. The report identifies the key trends shaping and driving the global Macular Degeneration market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Macular Degeneration sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. GlobalData valued the global macular degeneration therapeutics market at $1.3 billion in 2009. It is expected to grow to $3.0 billion with a Compound Annual Growth Rate (CAGR) of 10.4% by 2017. This growth is primarily attributed to the increase in the aged population across the world. Macular degeneration is a common disease that affects people above 50 years of age. Incidence is high in patients who are above 70 years. The growth will be supported by increased competition between the traditionally used off label products and the newly approved drugs and is expected to continue in the future. In 2009, Lucentis (ranibizumab) Scope The report provides information on the key drivers and challenges of the Macular Degeneration market. Its scope includes: * Annualized global Macular Degeneration market revenues data from 2001 to 2009, forecast for eight years to 2017. * Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as VEGF inhibitors, angiogenesis inhibitors, C5a receptor antagonists, antioxidants, tyrosine kinase inhibitosr, clotting factor inhibitors, cyclooxygenase inhibitors, RPE inhibitors, antioxidants, PDGF inhibitors, chemokine inhibitors, IL-2 inhibitors, retinol protein binders, a5B1 integrin antagonist, protein C3 inhibitors and mRNA targeting agents. * Analysis of the current and future competition in the global Macular Degeneration market. Key market players covered are Novartis AG, Bayer Pharma, Adeona Pharma, Ophthotech Corp., Alcon Inc, Pfizer Inc, Acucela Inc, Alimera Sciences, Neurotech Pharma, and Allergan Inc. * Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. * Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Macular Degeneration therapeutics market. Reasons to buy The report will enhance your decision making capability. It will allow you to: * Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. * Develop business strategies by understanding the trends shaping and driving the global Macular Degeneration market. * Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Macular Degeneration market in future. * Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. * Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. * Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. * What's the next big thing in the global Macular Degeneration market landscape? - Identify, understand and capitalize. For more information or to purchase this report, go to: - http://www.fastmr.com/ About GlobalData GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number